Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial

JAMA

Volumn 284, Issue 8, 2000, Pages 963-971

  Johnson, B A ^a   Roache, J D ^a   Javors, M A ^a   Diclemente, C C ^a   Cloninger, C R ^a   Prihoda, T J ^a   Bordnick, P S ^a   Ait Daoud, N ^a   Hensler, J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE DEFICIENT TRANSFERRIN; GELATIN; ONDANSETRON; SEROTONIN AGONIST;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG CAPSULE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0034705999     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.8.963     Document Type: Article

References (74)

1. 3 receptors and the neural actions of alcohols: An increasingly exciting topic
2. 3 receptor-mediated ion current by divalent metal cations in NCB-20 neuroblastoma cells
3. 3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells
4. Drug abuse by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
5. Neural mechanisms of drug reinforcement
6. A psychomotor stimulant theory of addiction
7. Neurobiological basis of drug reinforcement
8. 3 receptor in CNS disorders
9. 3 receptors in tat brain using radioligand binding
10. 4 receptors in terminal regions of the mesolimbic system
11. 3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset bran
12. 3 antagonist ICS 205-930
13. 3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats
14. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference
15. Animal models of alcoholism: Neurobiology of high alcohol-drinking behavior in rodents
16. 3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure
17. A review of central 5-HT receptors and their function
18. 3 antagonists fail to affect ethanol self-administration of rats
19. 3 receptor blockade: A preliminary study in healthy male volunteers
20. 3 receptor interactions in animals and humans
21. Ondansetron alters human alcohol intoxication
22. The effects of ondansetron pretreatment on acute responses to ethanol in social drinkers
23. 3 antagonist ondansetron in alcohol abuse and dependence
24. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population
25. Types of alcoholics: Concurrent and predictive validity of some common classifications schemes
26. The type A/type B distinction: Subtyping alcoholics according to indicators of vulnerability and severity
27. Neurogenetic adaptive mechanisms in alcoholism
28. Inheritance of alcohol abuse: Cross-fostering analysis of adopted men
29. Types of alcoholics, II: Application of an empirically derived typology to treatment matching
30. Age of onset for alcoholism and CSF homovanillic acid concentrations predict relapse
31. Buspirone treatment of alcoholism: Age of onset and cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid concentrations but not medication treatment predict return to drinking
32. Age of alcoholism onset, I: Relationship to psychopathology
33. Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic add levels than late-onset alcoholics
34. Serotonin in early-onset alcoholism
35. Serotonin in early onset, male alcoholics with violent behaviour
36. Alcoholism and serotonin: Relationships of plasma tryptophan availability to course of illness and clinical features
37. Alcohol and central serotonin metabolism in man
38. Serotonin and alcohol intake, abuse, and dependence: Clinical evidence
39. Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies
40. The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument
41. The Structured Clinical Interview for DSM-III-R (SCID), I: History, rationale, and description
42. The Structured Clinical Interview for DSM-III-R (SCID), II: Multisite test-retest reliability
43. New data from the addiction severity index: Reliability and validity scores from three centers
44. Timeline follow-back: A technique for assessing self-reported alcohol consumption
45. A modified method for the assay of carbohydrate-deficient transferrin (CDT) in serum
46. Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed
47. Utility of biological markers during outpatient treatment of alcohol dependent patients: Carbohydrate deficient transferrin responds to moderate changes in alcohol consumption
48. Carbohydrate-deficient transferrin as a marker of alcohol abuse: Relationship to alcohol consumption, severity of liver disease, and fibrogenesis
49. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment of alcohol scale (CIWA-Ar)
50. New methodologies for pharmacological treatment trials for alcohol dependence
51. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer
52. Self-efficacy; toward a unifying theory of behavioral change
53. Ensuring balanced distribution of prognostic factors in treatment outcome research
54. Testing for baseline balance in clinical trials
55. Chapter six: General linear model
56. Ondansetron and alcohol pharmacokinetics
57. Neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
58. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics
59. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: A pilot study
60. Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population
61. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
62. Cocaine, ethanol, and genotype effects on human mid-brain serotonin transporter binding sites and mRNA levels
63. Serotonergic agents and alcoholism treatment: Rebirth of the subtype concept - An interactive psychosocial and bio-molecular hypothesis
64. 3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding